跳至主要内容
临床试验/JPRN-C000000379
JPRN-C000000379已完成未知

Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06) - Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome in children: A randomized controlled trial (JSRDC06)

Japanese Study Group of Renal Disease in Children(JSRDC)0 个研究点目标入组 50 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1years-old 至 10years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.History of relapse. 2.Medical history of allergy or hypersensitivity reactions to mizoribine. 3.Poorly controlled hypertension. 4.Chronic renal dysfunction. 5.Active infectious disease. 6.Severe liver disfunction. 7.History of saireito and immunosupression administration. 8.Pregnancy. 9.Judged inappropriate for this study by the physicians.

研究者

发起方
Japanese Study Group of Renal Disease in Children(JSRDC)

相似试验